DOPAMINE IN SUBSTANTIA NIGRA AND CORTEX AFTER GAMMA-BUTYROLACTONE TREATMENT

被引：35

作者：

PERICIC, D ^{[1
]}

WALTERS, JR ^{[1
]}

机构：

[1] NINCDS, NEUROPHARMACOL LAB, BETHESDA, MD 20014 USA

来源：

JOURNAL OF PHARMACY AND PHARMACOLOGY | 1976年 / 28卷 / 06期

关键词：

D O I：

10.1111/j.2042-7158.1976.tb02784.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：527 / 530

页数：4

共 35 条

[1]

AGHAJANIAN GK, 1970, J PHARMACOL EXP THER, V175, P131

[2] CHEMICAL OR ELECTROLYTIC LESION OF SUBSTANTIA NIGRA - EARLY EFFECTS ON NEOSTRIATAL DOPAMINE METABOLISM [J].

AGID, Y ;

JAVOY, F ;

GLOWINSKI, J .

BRAIN RESEARCH, 1974, 74 (01) :41-49

[3] EFFECTS OF DRUGS INFLUENCING MONOAMINE MECHANISMS ON INCREASE IN BRAIN DOPAMINE PRODUCED BY AXOTOMY OR TREATMENT WITH GAMMAHYDROXYBUTYRIC ACID [J].

ANDEN, NE ;

MAGNUSSON, T ;

STOCK, G .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1973, 278 (04) :363-372

[4] HISTOCHEMICAL CONFIRMATION FOR DOPAMINERGIC INNERVATION OF RAT CEREBRAL-CORTEX AFTER DESTRUCTION OF NORADRENERGIC ASCENDING PATHWAYS [J].

BERGER, B ;

TASSIN, JP ;

BLANC, G ;

MOYNE, MA ;

THIERRY, AM .

BRAIN RESEARCH, 1974, 81 (02) :332-337

[5] DOPAMINE IN DENDRITES OF SUBSTANTIA NIGRA NEURONS - SUGGESTIONS FOR A ROLE IN DENDRITIC TERMINALS [J].

BJORKLUND, A ;

LINDVALL, O .

BRAIN RESEARCH, 1975, 83 (03) :531-537

[6]

CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140

[7]

CARLSSON A, 1972, PHARMACOL REV, V24, P371

[8] CATECHOLAMINES IN FETAL AND NEWBORN RAT-BRAIN [J].

COYLE, JT ;

HENRY, D .

JOURNAL OF NEUROCHEMISTRY, 1973, 21 (01) :61-67

[9] DOPAMINE RECEPTOR-BINDING - DIFFERENTIATION OF AGONIST AND ANTAGONIST STATES WITH H-3-DOPAMINE AND HALOPERIDOL-H-3 [J].

CREESE, I ;

BURT, DR ;

SNYDER, SH .

LIFE SCIENCES, 1975, 17 (06) :993-1001

[10]

EBSTEIN B, 1974, J PHARM PHARMACOL, V26, P995

← 1 2 3 4 →